GlassScriptPhysician profile
Joan L Abernethy
NPI 1871590471
$2,614.92
in general payments reported to CMS, 2019-2025
22 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $259 · 2021: $298 · 2022: $471 · 2023: $477 · 2024: $419 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379 · Entertainment: $31.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.42 |
| Entertainment | $31.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $697.17 | 2019-2025 | Clareon, Tryptyr, Luxor |
| Abbvie INC. | $275.11 | 2022-2025 | Durysta, Alphagan P, Lumigan |
| Novartis Pharmaceuticals Corporation | $256.06 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $226.74 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $185.32 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $143.68 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $134.49 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $134.04 | 2021-2025 | Cequa |
| Amgen INC. | $91.96 | 2025 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $60.40 | 2022-2024 | Veracity Surgical |
| Glaukos Corporation | $52.98 | 2024-2025 | Idosetr, Idose |
| Ivantis, INC | $51.93 | 2020 | |
| Oyster Point Pharma, INC. | $42.38 | 2022 | |
| Rayner Intraocular Lenses Limited | $41.37 | 2023-2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| Aerie Pharmaceuticals, INC. | $40.96 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.82 | 2020 | |
| Horizon Therapeutics Plc | $35.47 | 2021-2023 | Tepezza |
| Optos, INC. | $31.37 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $26.19 | 2025 | Oxervate |
| Harrow Eye, LLC | $23.37 | 2025 | Vevye |
| Rxsight INC | $14.54 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Eyevance Pharmaceuticals LLC | $12.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Abernethy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.